ASK REDCHAT ANYTHING ABOUT SPERO THERAPEUTICS INC.
Spero Therapeutics Inc. (NASDAQ: SPRO)
Listen to this Section
$2.10
N/A
(
0% )
1.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Tebipenem HBr (previously SPR994): oral carbapenemDetailsBacterial infection, Urinary tract infection |
Phase 3 |
| SPR206DetailsLung disease, Bacterial infection |
Phase 2 |
| SPR720DetailsLung disease, Bacterial infection |
Phase 2a |
| SPR720DetailsBacterial infection, Lung disease |
Failed |
Market Data
|
| Open |
$2.10 |
| Previous Close |
$2.10 |
| Volume |
1.0K |
| Market Cap |
$121.59M |
| Day Range |
$2.08 - $2.08 |
| 52 Week Range |
$1.80 - $3.08 |
| Shares Outstanding |
57.90M |
| Change % |
0% |
| Net Change |
N/A |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2017 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,306,857.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-02-05 |
Sale |
-239731.00 |
HAMED KAMAL |
| 2024-02-05 |
Sale |
-239731.00 |
JOSEPH TAMARA L |
| 2024-02-05 |
Sale |
-239731.00 |
Keutzer Timothy |
| 2024-02-05 |
Sale |
-63795.00 |
Mahadevia Ankit |
| 2024-02-05 |
Sale |
-679501.00 |
Shukla Sath |
| 2024-01-04 |
Sale |
-35604.00 |
Tregoning Kathleen |
| 2023-11-15 |
Sale |
-300000.00 |
Rajavelu Esther |
| 2023-10-10 |
Sale |
-20000.00 |
Pottage John C Jr |
| 2023-10-10 |
Sale |
-20000.00 |
Smith Cynthia |
| 2023-10-10 |
Sale |
-20000.00 |
Jackson Scott Thomas |